Company attributes
Venture Capital Firm attributes
Other attributes
Tekes is a Finnish funding agency specialized in research communities, industry, and service sectors. Founded 1983 in Helsinki, Southern Finland, Finland, this government office and venture capital firm invests in debt, early stage ventures and seed. Its portfolio companies include Valo Therapeutics, TactoTek, Nightingale Health, Invesdor, and Sulapac. As of February 2020, Tekes has made 91 investments. Their most recent investment was on Feb 6, 2020, when Valo Therapeutics raised €1.1M. Tekes has had 5 exits. Tekes's most notable exits include Framery, Faron Pharmaceuticals, and Applifier. The company has raised a single venture fund, DIMECC Design for Value (D4V).